• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉萎缩性侧索硬化症中的细胞衰老和老化。

Cellular Senescence and Aging in Myotonic Dystrophy.

机构信息

Department of Neurology, Osaka University Graduate School of Medicine, Suita 565-0871, Osaka, Japan.

出版信息

Int J Mol Sci. 2022 Feb 20;23(4):2339. doi: 10.3390/ijms23042339.

DOI:10.3390/ijms23042339
PMID:35216455
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8877951/
Abstract

Myotonic dystrophy (DM) is a dominantly inherited multisystemic disorder affecting various organs, such as skeletal muscle, heart, the nervous system, and the eye. Myotonic dystrophy type 1 (DM1) and type 2 (DM2) are caused by expanded CTG and CCTG repeats, respectively. In both forms, the mutant transcripts containing expanded repeats aggregate as nuclear foci and sequester several RNA-binding proteins, resulting in alternative splicing dysregulation. Although certain alternative splicing events are linked to the clinical DM phenotypes, the molecular mechanisms underlying multiple DM symptoms remain unclear. Interestingly, multi-systemic DM manifestations, including muscle weakness, cognitive impairment, cataract, and frontal baldness, resemble premature aging. Furthermore, cellular senescence, a critical contributor to aging, is suggested to play a key role in DM cellular pathophysiology. In particular, several senescence inducers including telomere shortening, mitochondrial dysfunction, and oxidative stress and senescence biomarkers such as cell cycle inhibitors, senescence-associated secretory phenotype, chromatin reorganization, and microRNA have been implicated in DM pathogenesis. In this review, we focus on the clinical similarities between DM and aging, and summarize the involvement of cellular senescence in DM and the potential application of anti-aging DM therapies.

摘要

强直性肌营养不良症 (DM) 是一种显性遗传性多系统疾病,影响多种器官,如骨骼肌、心脏、神经系统和眼睛。1 型和 2 型强直性肌营养不良症分别由扩展的 CTG 和 CCTG 重复引起。在这两种形式中,含有扩展重复的突变转录本聚集成核焦点,并隔离几种 RNA 结合蛋白,导致选择性剪接失调。尽管某些选择性剪接事件与临床 DM 表型相关,但多系统 DM 症状的分子机制仍不清楚。有趣的是,多系统 DM 表现,包括肌肉无力、认知障碍、白内障和额秃,类似于早衰。此外,细胞衰老作为衰老的关键贡献者,被认为在 DM 细胞病理生理学中发挥关键作用。特别是,几种衰老诱导剂,包括端粒缩短、线粒体功能障碍和氧化应激以及衰老生物标志物,如细胞周期抑制剂、衰老相关分泌表型、染色质重排和 microRNA,都与 DM 发病机制有关。在这篇综述中,我们重点关注 DM 和衰老之间的临床相似性,并总结细胞衰老在 DM 中的作用以及抗衰老 DM 疗法的潜在应用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fed/8877951/7c097c5d1ba6/ijms-23-02339-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fed/8877951/85b6ebcead1b/ijms-23-02339-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fed/8877951/7c097c5d1ba6/ijms-23-02339-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fed/8877951/85b6ebcead1b/ijms-23-02339-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fed/8877951/7c097c5d1ba6/ijms-23-02339-g002.jpg

相似文献

1
Cellular Senescence and Aging in Myotonic Dystrophy.肌肉萎缩性侧索硬化症中的细胞衰老和老化。
Int J Mol Sci. 2022 Feb 20;23(4):2339. doi: 10.3390/ijms23042339.
2
Zebrafish deficient for Muscleblind-like 2 exhibit features of myotonic dystrophy.肌肉盲样蛋白 2 缺陷型斑马鱼表现出肌强直性营养不良的特征。
Dis Model Mech. 2011 May;4(3):381-92. doi: 10.1242/dmm.004150. Epub 2011 Feb 8.
3
Expanded CUG Repeat RNA Induces Premature Senescence in Myotonic Dystrophy Model Cells.扩展的CUG重复RNA在强直性肌营养不良模型细胞中诱导早衰。
Front Genet. 2022 Mar 25;13:865811. doi: 10.3389/fgene.2022.865811. eCollection 2022.
4
Myotonic dystrophy: emerging mechanisms for DM1 and DM2.强直性肌营养不良:DM1和DM2的新机制
Biochim Biophys Acta. 2007 Feb;1772(2):195-204. doi: 10.1016/j.bbadis.2006.05.013. Epub 2006 Jun 20.
5
Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts.缺乏肌盲蛋白的果蝇呈现强直性肌营养不良的模型特征,伴有Z带相关转录本剪接形式的改变。
Hum Genet. 2006 Nov;120(4):487-99. doi: 10.1007/s00439-006-0228-8. Epub 2006 Aug 23.
6
Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.强直性肌营养不良:1型和2型强直性肌营养不良之间的临床与分子相似性
Curr Neurol Neurosci Rep. 2002 Sep;2(5):465-70. doi: 10.1007/s11910-002-0074-6.
7
Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2.肌肉盲样蛋白1核隔离是1型和2型强直性肌营养不良症的分子病理学标志物。
Eur J Histochem. 2006 Jul-Sep;50(3):177-82.
8
Clinical and Molecular Insights into Gastrointestinal Dysfunction in Myotonic Dystrophy Types 1 & 2.1 型和 2 型肌强直性营养不良症胃肠道功能障碍的临床和分子见解。
Int J Mol Sci. 2022 Nov 26;23(23):14779. doi: 10.3390/ijms232314779.
9
Molecular mechanisms of muscle atrophy in myotonic dystrophies.肌强直性营养不良症中肌肉萎缩的分子机制。
Int J Biochem Cell Biol. 2013 Oct;45(10):2280-7. doi: 10.1016/j.biocel.2013.06.010. Epub 2013 Jun 21.
10
Transcriptome alterations in myotonic dystrophy skeletal muscle and heart.肌强直性营养不良骨骼肌和心脏的转录组改变。
Hum Mol Genet. 2019 Apr 15;28(8):1312-1321. doi: 10.1093/hmg/ddy432.

引用本文的文献

1
Repeat Expansion and Somatic Instability in TCF4 in Patients With Fuchs Endothelial Corneal Dystrophy Identified by Small Pool PCR.通过小池聚合酶链反应鉴定的Fuchs内皮性角膜营养不良患者中TCF4的重复扩增和体细胞不稳定性
Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):14. doi: 10.1167/iovs.66.11.14.
2
Molecular genetics of myotonic dystrophy and the evolution of therapeutic approaches.强直性肌营养不良的分子遗传学与治疗方法的演变
J Hum Genet. 2025 Jul 3. doi: 10.1038/s10038-025-01358-6.
3
Societal Costs, Healthcare Utilisation and Labour Market Affiliation of Persons With Adult-Onset Myotonic Dystrophy Type 1 (DM1)-A Register-Based Study II.

本文引用的文献

1
The role of cellular senescence in cardiac disease: basic biology and clinical relevance.细胞衰老在心脏疾病中的作用:基础生物学与临床相关性。
Nat Rev Cardiol. 2022 Apr;19(4):250-264. doi: 10.1038/s41569-021-00624-2. Epub 2021 Oct 19.
2
Endocrine Dysfunction in Patients With Myotonic Dystrophy.肌强直性营养不良患者的内分泌功能障碍。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):2819-2827. doi: 10.1210/clinem/dgab430.
3
New insights into molecular changes in skeletal muscle aging and disease: Differential alternative splicing and senescence.
成人迟发型1型强直性肌营养不良(DM1)患者的社会成本、医疗保健利用及劳动力市场归属——一项基于登记处的研究II
Eur J Neurol. 2025 Jun;32(6):e70211. doi: 10.1111/ene.70211.
4
Multisystem Symptoms in Myotonic Dystrophy Type 1: A Management and Therapeutic Perspective.1型强直性肌营养不良的多系统症状:管理与治疗视角
Int J Mol Sci. 2025 Jun 2;26(11):5350. doi: 10.3390/ijms26115350.
5
Multiorgan Involvement and Mortality in Individuals With Adult-Onset Myotonic Dystrophy (DM1)-A Danish Register-Based Study I.成人起病型强直性肌营养不良(DM1)患者的多器官受累与死亡率——一项基于丹麦登记处的研究I
Eur J Neurol. 2025 Apr;32(4):e70135. doi: 10.1111/ene.70135.
6
Functions of the Muscleblind-like protein family and their role in disease.肌肉盲样蛋白家族的功能及其在疾病中的作用。
Cell Commun Signal. 2025 Feb 18;23(1):97. doi: 10.1186/s12964-025-02102-5.
7
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target.1型强直性肌营养不良的新视野:细胞衰老作为治疗靶点
Bioessays. 2025 Mar;47(3):e202400216. doi: 10.1002/bies.202400216. Epub 2024 Dec 26.
8
Common Characteristics Between Frailty and Myotonic Dystrophy Type 1: A Narrative Review.脆弱与1型强直性肌营养不良之间的共同特征:一篇叙述性综述。
Aging Dis. 2024 Aug 29;16(4):2120-2131. doi: 10.14336/AD.2024.0950.
9
Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration.研究 MBNL1 和 MBNL2 缺失对骨骼肌再生的影响。
Int J Mol Sci. 2024 Feb 26;25(5):2687. doi: 10.3390/ijms25052687.
10
Preliminary evaluation of the proteomic profiling in the hippocampus of aged grazing cattle.老龄放牧牛海马蛋白质组图谱的初步评估
Front Aging Neurosci. 2023 Oct 27;15:1274073. doi: 10.3389/fnagi.2023.1274073. eCollection 2023.
骨骼肌衰老和疾病中分子变化的新见解:差异剪接和衰老。
Mech Ageing Dev. 2021 Jul;197:111510. doi: 10.1016/j.mad.2021.111510. Epub 2021 May 19.
4
Molecular Pathways of Cellular Senescence and Placental Aging in Late Fetal Growth Restriction and Stillbirth.晚期胎儿生长受限和死胎中细胞衰老和胎盘衰老的分子途径。
Int J Mol Sci. 2021 Apr 18;22(8):4186. doi: 10.3390/ijms22084186.
5
Myotonic dystrophy type 1 drug development: A pipeline toward the market.1 型肌强直性营养不良药物研发:走向市场的管线。
Drug Discov Today. 2021 Jul;26(7):1765-1772. doi: 10.1016/j.drudis.2021.03.024. Epub 2021 Mar 31.
6
Duchenne muscular dystrophy.杜氏肌营养不良症。
Nat Rev Dis Primers. 2021 Feb 18;7(1):13. doi: 10.1038/s41572-021-00248-3.
7
Human brain pathology in myotonic dystrophy type 1: A systematic review.1 型肌强直性营养不良的人脑病理学:系统评价。
Neuropathology. 2021 Feb;41(1):3-20. doi: 10.1111/neup.12721.
8
Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1.转录组分析揭示了 1 型强直性肌营养不良诱导性神经胶质细胞模型中炎症途径的改变。
Biomolecules. 2021 Jan 26;11(2):159. doi: 10.3390/biom11020159.
9
Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening Program.基于全州血液筛查计划的遗传分析的 1 型肌强直性营养不良的人群患病率。
Neurology. 2021 Feb 16;96(7):e1045-e1053. doi: 10.1212/WNL.0000000000011425. Epub 2021 Jan 20.
10
Cellular senescence in ageing: from mechanisms to therapeutic opportunities.细胞衰老与衰老:从机制到治疗机会。
Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95. doi: 10.1038/s41580-020-00314-w. Epub 2020 Dec 16.